Udo Reichl
Udo Reichl
Max Planck Institute / Otto von Guericke University Magdeburg, Germany
Bestätigte E-Mail-Adresse bei mpi-magdeburg.mpg.de
Titel
Zitiert von
Zitiert von
Jahr
Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture
Y Genzel, I Behrendt, S König, H Sann, U Reichl
Vaccine 22 (17-18), 2202-2208, 2004
1812004
Structured model of influenza virus replication in MDCK cells
Y Sidorenko, U Reichl
Biotechnology and bioengineering 88 (1), 1-14, 2004
1712004
Metabolic effects of influenza virus infection in cultured animal cells: Intra-and extracellular metabolite profiling
JB Ritter, AS Wahl, S Freund, Y Genzel, U Reichl
BMC systems biology 4 (1), 61, 2010
1542010
Continuous cell lines as a production system for influenza vaccines
Y Genzel, U Reichl
Expert review of vaccines 8 (12), 1681-1692, 2009
1542009
Metagenome and metaproteome analyses of microbial communities in mesophilic biogas-producing anaerobic batch fermentations indicate concerted plant carbohydrate degradation
A Hanreich, U Schimpf, M Zakrzewski, A Schlüter, D Benndorf, R Heyer, ...
Systematic and applied microbiology 36 (5), 330-338, 2013
1532013
Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media
Y Genzel, RM Olmer, B Schäfer, U Reichl
Vaccine 24 (35-36), 6074-6087, 2006
1372006
Comparative performance of four methods for high-throughput glycosylation analysis of immunoglobulin G in genetic and epidemiological research
JE Huffman, M Pučić-Baković, L Klarić, R Hennig, MHJ Selman, ...
Molecular & Cellular Proteomics 13 (6), 1598-1610, 2014
1302014
Mathematical model of influenza A virus production in large‐scale microcarrier culture
L Möhler, D Flockerzi, H Sann, U Reichl
Biotechnology and bioengineering 90 (1), 46-58, 2005
1302005
Substitution of glutamine by pyruvate to reduce ammonia formation and growth inhibition of mammalian cells
Y Genzel, JB Ritter, S König, R Alt, U Reichl
Biotechnology progress 21 (1), 58-69, 2005
1162005
Purification of cell culture‐derived human influenza A virus by size‐exclusion and anion‐exchange chromatography
B Kalbfuss, M Wolff, R Morenweiser, U Reichl
Biotechnology and bioengineering 96 (5), 932-944, 2007
1142007
Monitoring influenza virus content in vaccine production: precise assays for the quantitation of hemagglutination and neuraminidase activity
B Kalbfuss, A Knöchlein, T Kröber, U Reichl
Biologicals 36 (3), 145-161, 2008
1132008
Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture
Y Genzel, M Fischer, U Reichl
Vaccine 24 (16), 3261-3272, 2006
1062006
Simultaneous extraction of several metabolites of energy metabolism and related substances in mammalian cells: optimization using experimental design
JB Ritter, Y Genzel, U Reichl
Analytical biochemistry 373 (2), 349-369, 2008
1052008
Mathematical model for apical growth, septation, and branching of mycelial microorganisms
H Yang, R King, U Reichl, ED Gilles
Biotechnology and Bioengineering 39 (1), 49-58, 1992
1031992
Quantitative analysis of cellular proteome alterations in human influenza A virus‐infected mammalian cell lines
D Vester, E Rapp, D Gade, Y Genzel, U Reichl
Proteomics 9 (12), 3316-3327, 2009
1002009
The MetaProteomeAnalyzer: a powerful open-source software suite for metaproteomics data analysis and interpretation
T Muth, A Behne, R Heyer, F Kohrs, D Benndorf, M Hoffmann, M Lehteva, ...
Journal of proteome research 14 (3), 1557-1565, 2015
992015
New avian suspension cell lines provide production of influenza virus and MVA in serum-free media: studies on growth, metabolism and virus propagation
V Lohr, A Rath, Y Genzel, I Jordan, V Sandig, U Reichl
Vaccine 27 (36), 4975-4982, 2009
982009
Glycan analysis in cell culture-based influenza vaccine production: influence of host cell line and virus strain on the glycosylation pattern of viral hemagglutinin
J Schwarzer, E Rapp, R Hennig, Y Genzel, I Jordan, V Sandig, U Reichl
Vaccine 27 (32), 4325-4336, 2009
912009
N‐glycan analysis by CGE–LIF: Profiling influenza A virus hemagglutinin N‐glycosylation during vaccine production
J Schwarzer, E Rapp, U Reichl
Electrophoresis 29 (20), 4203-4214, 2008
912008
Downstream processing of cell culture-derived virus particles
MW Wolf, U Reichl
Expert Review of Vaccines 10 (10), 1451-1475, 2011
882011
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20